3Ma M.Causes of death after congenital heart surgery.Ann Thorac Surg,2007,83:1438-1445.
4Komai H,Adatia IT,Elliott MJ,et al.Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease.J Thorac Cardiovasc Surg,1993,106:473-478.
5Humbert M,Morrell NW,Archer SL,et al.Cellular and molecular pathobiology of pulmonary arterial hypertension.J Am Coll Cardiol,2004,43(12 Suppl S):13S -24S.
7Fratz S,Geiger R,Kresse H,et al.Pulmonary blood pressure,not flow,is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance.J Thorac Cardiovasc Surg,2003,126:1724 -1729.
8Rondelet B,Kerbaul F,Motte S,et al.Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension.Circulation,2003,107:1329-1335.
9Jia B,Zhang S,Chen Z,et al.Plasma endothelin 1 concentrations in children with congenital heart defects.Minerva Pediatr,1998,50:99-103.
10Curran R,Mavroudis C,Backer C,et al.Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.Ann Thorac Surg,1995,60:1765-1771.
